Your browser doesn't support javascript.
loading
Identifying a candidate population for ovarian conservation in young women with clinical stage IB-IIB cervical cancer.
Matsuo, Koji; Shimada, Muneaki; Yamaguchi, Satoshi; Kanao, Hiroyuki; Nakanishi, Toru; Saito, Toshiaki; Kamiura, Shoji; Iwata, Takashi; Mikami, Mikio; Sugiyama, Toru.
Afiliação
  • Matsuo K; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, CA.
  • Shimada M; Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA.
  • Yamaguchi S; Department of Obstetrics and Gynecology, Tottori University, Tottori, Japan.
  • Kanao H; Department of Gynecologic Oncology, Hyogo Cancer Center, Hyogo, Japan.
  • Nakanishi T; Department of Gynecology, Cancer Institute Hospital, Tokyo, Japan.
  • Saito T; Department of Gynecologic Oncology, Aichi Cancer Center Hospital, Japan.
  • Kamiura S; Gynecology Service, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
  • Iwata T; Department of Gynecologic Oncology, Osaka International Cancer Institute, Osaka, Japan.
  • Mikami M; Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan.
  • Sugiyama T; Department of Obstetrics and Gynecology, Tokai University, Kanagawa, Japan.
Int J Cancer ; 142(5): 1022-1032, 2018 03 01.
Article em En | MEDLINE | ID: mdl-28975603
ABSTRACT
This study seeks to identify risk factors associated with ovarian metastasis and to characterize a population with minimum risk of ovarian metastasis in young women with stage IB-IIB cervical cancer. This was a nation-wide multicenter retrospective study in Japan examining consecutive cases of surgically-treated women with clinical stage IB-IIB cervical cancer who had oophorectomy at radical hysterectomy (n = 5,697). Multivariable analysis was performed to identify independent risk factors for ovarian metastasis. Ovarian metastasis was seen in 70 (1.2%, 95% confidence interval 0.9-1.5) cases. In the entire cohort, adenocarcinoma, lympho-vascular space invasion, uterine corpus tumor invasion, and pelvic/para-aortic nodal metastases remained independent risk factors for ovarian metastasis (all, adjusted-p < 0.05). In a sensitivity analysis of 3,165 women aged <50 years (ovarian metastasis, 1.0%), adenocarcinoma, parametrial tumor involvement, uterine corpus tumor involvement, and pelvic/para-aortic nodal metastases remained independent risk factors for ovarian metastasis (all, adjusted-P < 0.05). In the absence of these five risk factors (representing 46.1% of women aged <50 years), the incidence of ovarian metastasis was 0.14%. With the presence of adenocarcinoma alone (representing 18.9% of women aged <50 years), the incidence of ovarian metastasis was 0.17% and was not associated with increased risk of ovarian metastasis compared to the subgroup without any risk factors (p = 0.87). In conclusion, nearly two thirds of women aged <50 years with clinical stage IB-IIB cervical cancer had no risk factor for ovarian metastasis or had adenocarcinoma alone these subgroups had ovarian metastasis rates of around 0.1% and may be a candidate population for ovarian conservation at surgical treatment.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Carcinoma de Células Escamosas / Adenocarcinoma / Tratamentos com Preservação do Órgão Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Middle aged País/Região como assunto: Asia Idioma: En Revista: Int J Cancer Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Carcinoma de Células Escamosas / Adenocarcinoma / Tratamentos com Preservação do Órgão Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Middle aged País/Região como assunto: Asia Idioma: En Revista: Int J Cancer Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Canadá